Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases.

Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases.
Ageing Res Rev. 2016 Nov 6;:
Authors: Vitiello M, Zullo A, Servillo L, Mancini FP, Borriello A, Giovane A, Ragione FD, D'Onofrio N, Balestrieri ML
Abstract
Sirtuin 6 (SIRT6) is a member of the sirtuin family NAD(+)-dependent deacetylases with multiple roles in controlling organism homeostasis, lifespan, and diseases. Due to its complex and opposite functional roles, this sirtuin is considered a two-edged sword in health and disease. Indeed, SIRT6 improves longevity, similarly to the founding yeast member, silent information regulator-2 (Sir2), and modulates genome stability, telomere integrity, transcription, and DNA repair. Its deficiency is associated with chronic inflammation, diabetes, cardiac hypertrophy, obesity, liver dysfunction, muscle/adipocyte disorders, and cancer. Besides, pieces of evidence showed that SIRT6 is a promoter of specific oncogenic pathways, thus disclosing its dual role regarding cancer development. Collectively, these findings suggest that multiple mechanisms, to date not entirely known, underlie the intriguing roles of SIRT6. Here we provide an overview of the current molecular mechanisms through which SIRT6 controls cancer and heart diseases, and describe its recent implications in the atherosclerotic plaque development.
PMID: 27829173 [PubMed - as supplied by publisher]

Source: Ageing Research Reviews - November 5, 2016 Category: Genetics & Stem Cells Authors: Vitiello M, Zullo A, Servillo L, Mancini FP, Borriello A, Giovane A, Ragione FD, D'Onofrio N, Balestrieri ML Tags: Ageing Res Rev Source Type: research